Environmental Intolerances and Toxins-Chemical:  Background Information
Environmental Intolerances Menu

Endocrine Disruptors

CITATION:  Solomon, G.M. and Schettler, T.  (2000).  Environment and health: 6. Endocrine disruption and potential human health implications. CMAJ: 163 (11).


During the past 50 years, tens of thousands of chemicals have been synthesized and released into the general environment. Some of these chemicals inadvertently interfere with hormone function in animals and, in somecases, humans. The public health implications of these so-called endocrine disruptors have been the subject of scientific debate, media interest and policy attention over the past several years. The current scientific debate centres on whether there is evidence of significant risks to the general human population.1

The health care community should be familiar with this issue because it is increasingly a subject of the popular press and is a topic of concern to patients, who may present with questions. But health policy decisions are currently being made with little input from the medical and public health community. In this article we review the history of environmental endocrine disruption, the mechanisms of action of endocrine disruptors and the current evidence of effects on reproduction, infant development and neurobehavioural function. Finally, we discuss health policy activities worldwide that are relevant to endocrine-disrupting chemicals in the environment.

Table 1: Examples of endocrine-disrupting chemicals


Health effect
Synthetic estrogen
Estrogen receptor agonist
Humans (prenatal exposure): vaginal
cancer, reproductive tract abnormalities
(females); cryptorchidism, hypospadias,
semen abnormalities (males)
Metabolite is an estrogen
receptor agonist
Rodents: accelerated puberty, abnormal
ovarian cycling (females); aggressive
behaviour (males)
Metabolite (DDE) is an androgen
receptor antagonist
Rodents (males): delayed puberty,
reduced sex accessory gland size,
altered sex differentiation
Androgen receptor antagonist
Rodents (males): feminization, nipple
development, hypospadias
No longer manufactured;
still in electrical
transformers, capacitors,
toxic waste sites, food chain
Accelerated T4 metabolism,
decreased T4 levels, elevated
TSH levels
(high doses: thyromimetic)
Humans (in utero exposure): delayed
neurological development; IQ deficits
Reduces gonadotropin-releasing
hormone from hypothalamus,
reduces pituitary LH levels,
interferes with metabolism of
estradiol, blocks estrogen
receptor binding
Rodents (females): mammary tumours,
abnormal ovarian cycling
Humans: some evidence of breast and
ovarian tumours
By-product of industrial
processes including waste
incineration; food
Aryl hydrocarbon receptor
agonist; increases estrogen
metabolism, decreases estrogenmediated
gene transcription,
decreases estrogen levels,
decreases testosterone levels by
interfering with HPG axis
Rodents (in utero exposure): delayed
puberty, increased susceptibility to
mammary cancer (females); decreased
testosterone, hypospadias,
hypospermia, delayed testicular
descent, feminized sexual behaviour
Humans: decreased T3 and T4 levels,
decreased testosterone levels,* cancer*
Note: DES = diethylstilbestrol, DDT = dichlorodiphenyltrichloroethane, PCBs = polychlorinated biphenyls, T4 = thyroxine, TSH = thyroid stimulating hormone, IQ = intelligence quotient, LH =
luteinizing hormone, HPG axis = hypothalamic–pituitary–gonadal axis, T3 = triiodothyronine.
*Exposures in adults.

Table 2: Trends in human health effects potentially related to endocrine function

End point

Degree of change
Increasing incidence
4.3% per year
3.3% per year
Increasing incidence
3.5% per year
1.6% per year
Sperm count
–0.7%/mL per year*
–3%/mL per year
–5.3%/mL per year
Testicular cancer
Increasing incidence
2.1% per year
2.3% per year
2.3%–5.2% per year†
Prostate cancer
Increasing incidence‡
3% per year
5.3% per year
Breast cancer
Increasing incidence
3.3% per year
1.9% per year
Sex ratio
Shift toward females
–1.0 males/10 000 per year
–0.5 males/10 000 per year
Age at breast
Shifting earlier
11.2–9.96 years in white
*This trend disappears when data from before 1984 are included.
†Range is dependent on country, with Sweden at the lower and the former East Germany at the upper end of the range.
‡International trends in prostate cancer are complicated by the introduction of the prostate specific antigen screen, but prostate cancer mortality also increased (by about 1% per year through 1995 in the US and Canada), implying that improved diagnosis may not fully explain the rising incidence trends.


1. Committee on Hormonally Active Agents in the Environment, National Research
Council. Hormonally active agents in the environment.
Washington: National  <>Academy Press; 1999.

2. Dodds EC, Lawson W. Molecular structure in relation to oestrogenic activity.  Compounds without a phenanthrene nucleus. Proc R Soc London 1938;125:222-32. 

Burlington H, Lindeman VF. Effect of DDT on testes and secondary sex characters   <>of white leghorn cockerels. Proc Soc Exp Biol Med 1950;74:48-51.

4. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the
long-term health effects. Ann Intern Med 1995;122:778-88.

5. Reinisch JM, Ziemba-Davis M, Sanders SA. Hormonal contributions to sexually
dimorphic behavior in humans. Psychoneuroendocrinology 1991;16:213-78.

6. Cooper RL, Kavlock RJ. Endocrine disruptors and reproductive development: a
<>weight-of-evidence overview. J Endocrinol 1997;152:159-66.

7. Swartz WJ, Corkern M. Effects of methoxychlor treatment of pregnant mice
on female offspring of the treated and subsequent pregnancies. Reprod Toxicol

8. Brouwer A, Morse DC, Lans MC, Schuur AG, Murk AJ, Klasson-Wehler E, et
al. Interactions of persistent environmental organohalogens with the thyroid
hormone system: mechanisms and possible consequences for animal and human
health. Toxicol Ind Health 1998;14:59-84.

9. Bigsby R, Chapin RE, Daston GP, Davis BJ, Gorski J, Gray LE, et al. Evaluating the effects of endocrine disruptors on endocrine function during development. Environ Health Perspect 1999;107(Suppl 4):613-8.

10. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et
al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341(8):549-55.

11. Crisp TM, Clegg ED, Cooper RL, Wood WP, Anderson DG, Baetcke KP, et
al. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 1998;106(Suppl 1):11-56.

12. Vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, Nagel SC, et
al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production,
and behavior. Toxicol Ind Health 1998;14:239-60.

13. Vom Saal FS, Nagel SC, Palanza P, Boechler M, Parmigiani S, Welshons WV. Estrogenic pesticides: binding relative to estradiol in MCF-7 cells and effects of exposure during fetal life on subsequent territorial behavior in male mice. Toxicol Lett 1995;77(1-3):343-50.

14. Gray LE. Xenoendocrine disruptors: laboratory studies on male reproductive
effects. Toxicol Lett 1998;102-103:331-5.

15. Gray LE, Ostby J, Monosson E, Kelce WR. Environmental antiandrogens: low
doses of the fungicide vinclozolin alter sexual differentiation of the male rat.
Toxicol Ind Health 1999;15(1-2):48-64.

16. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to
polychlorinated biphenyls in utero. N Engl J Med 1996;335:783-9.

17. Zoeller RT, Dowling A, Vas AA. Developmental exposure to polychlorinated
biphenyls exerts thyroid-like effects on the expression of RC3/neurogranin and
myelin basic protein messenger ribonucleic acids in the developing rat brain.
Endocrinology 2000;141:181-9.

18. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R. Effects of pesticides on
the ratio of 16α/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ
Health Perspect 1995;103(Suppl 7):147-50.

19. Tran DQ, Kow KY, McLachlan JA, Arnold SF. The inhibition of estrogen receptor-mediated responses by chloro-s-triazine-derived compounds is dependent on estradiol concentration in yeast. Biochem Biophys Res Commun 1996;227: 140-6.

20. Cooper RL, Goldman JM, Stoker TE. Neuroendocrine and reproductive effects
of contemporary-use pesticides. Toxicol Ind Health 1999;15:26-36.

21. Donna A, Crosignani P, Robutti F, Betta PG, Bocca R, Mariani N, et al. Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health 1989;15:47-53.

22. Kettles MA, Browning SR, Prince TS, Horstman SW. Triazine herbicide exposure and breast cancer incidence: an ecologic study of Kentucky counties. Environ Health Perspect 1996;105:1222-7.

23. Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA. Prenatal
TCDD and predisposition to mammary cancer in the rat. Carcinogenesis

24. Mably TA, Moore RW, Peterson RE. In utero and lactational exposure of male
rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: 1. Effects on androgenic status.
Toxicol Appl Pharmacol 1992;114:97-107.

25. Egeland GM, Sweeney MH, Fingerhut MA, Wille KK, Schnorr TM, Halperin
WE. Total serum testosterone and gonadotropins in workers exposed to dioxin.
Am J Epidemiol 1994;139(3):272-81.

26. Nagayama J, Okamura K, Iida T, Hirakawa H, Matsueda T, Tsuji H, et al.
Postnatal exposure to chlorinated dioxins and related chemicals on thyroid hormone status in Japanese breast-fed infants. Chemosphere 1998;37(9-12):1789-93.

27. Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI. Cancer, heart
disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-pdioxin.
J Natl Cancer Inst 1999;91(9):779-86.

28. Steenland K, Cedillo L, Tucker J, Hines C, Sorensen K, Deddens J, et al. Thyroid hormones and cytogenetic outcomes in backpack sprayers using ethylenebis(dithiocarbamate) (EBDC) fungicides in Mexico. Environ Health Perspect 1997;105:1126-30.

29. Sweeney MH, Calvert GM, Egeland GA, Fingerhut MA, Halperin WE,
Piacitelli LA. Review and update of the results of the NIOSH medical study of
workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin.
Teratog Carcinog Mutagen 1997-98;17(4-5):241-7.

30. Manzo L, Artigas F, Martinez E, Mutti A, Bergamaschi E, Nicotera P, et al.
Biochemical markers of neurotoxicity: a review of mechanistic studies and applications. Hum Exp Toxicol 1996;15(Suppl 1):S20-35.

31. Hardell L, Ohlson CG, Fredrikson M. Occupational exposure to polyvinyl
chloride as a risk factor for testicular cancer evaluated in a case–control study.
Int J Cancer 1997;73:828-30.

32. Whelan EA, Grajewski B, Wild DK, Schnorr TM, Alderfer R. Evaluation of
reproductive function among men occupationally exposed to a stilbene derivative:
II. Perceived libido and potency. Am J Ind Med 1996;29:59-65.

33. Gold EB, Tomich E. Occupational hazards to fertility and pregnancy outcome.
Occup Med 1994;9:435-69.

34. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 1998;106: 793-6.

35. Hunter DJ, Hankinson SE, Laden F, Colditz GA, Colditz GA, Manson JE,
Willett WC, et al. Plasma organochlorine levels and the risk of breast cancer. N
Engl J Med 1997;337:1253-8.

36. Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hartvig HB. Organochlorine
exposure and risk of breast cancer. Lancet 1998;352:1816-20.

37. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism.
Environ Health Perspect 1999;107:297-302.

38. Younglai EV, Collins JA, Foster WG. Canadian semen quality: an analysis of
sperm density among eleven academic fertility centers. Fertil Steril 1998;70:76-80.

39. Swan S, Elkin EP, Fenster L. Have sperm densities declined? A reanalysis of
global trend data. Environ Health Perspect 1997;105:1228-32.

40. Liu S, Wen SW, Mao Y, Mery L, Rouleau J. Birth cohort effects underlying
the increasing testicular cancer incidence in Canada. Can J Public Health

41. McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H. Rising risk of
testicular cancer by birth cohort in the United States from 1973–1995. J Urol

42. Bergstrom R, Adami HO, Mohner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst

43. Levy IG, Iscoe NA, Klotz LH. Prostate cancer. 1. The descriptive epidemiology
in Canada. CMAJ 1998;159(5):509-13. Available:

44. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin

45. Wang PP, Cao Y. Incidence trends of female breast cancer in Saskatchewan,
1932-1990. Breast Cancer Res Treat 1996;37(3):197-207.

46. Wolff MS, Collman GW, Barrett JC, Huff J. Breast cancer and environmental
risk factors: epidemiological and experimental findings. Annu Rev Pharmacol
Toxicol 1996;36:573-96.

47. Allan BB, Brant R, Seidel JE, Jarrell JF. Declining sex ratios in Canada. CMAJ
1997;156(1):37-41. Abstract available:

48. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV,
Koch GG, et al. Secondary sexual characteristics and menses in young girls seen
in office practice: a study from the Pediatric Research in Office Settings network.
Pediatrics 1997;99:505-12.

49. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette Health Perspect 1996;104(Suppl 4):741-803.

50. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts
and disorders of the male reproductive tract? Lancet 1993;341:1392-5.

51. Gardner WA. Hypothesis: the prenatal origins of prostate cancer. Hum Pathol

52. Davis DL, Axelrod D, Osborne M, Telang N, Bradlow HL, Sittner E. Avoidable
causes of breast cancer: the known, unknown, and the suspected. Ann N Y
Acad Sci 1997;833:112-28.

53. Mably TA, Moore RW, Goy RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlordibenzo-p-dioxin. 2. Effects on sexual behavior and the regulation of LH secretion in adulthood. Toxicol Appl Pharmacol

54. Leatherland JF. Changes in thyroid hormone economy following consumption
of environmentally contaminated Great Lakes fish. Toxicol Ind Health 1998;

55. Daly HB, Stewart PW, Lunkenheimer L, Sargent D. Maternal consumption of
Lake Ontario salmon in rats produces behavioral changes in the offspring. Toxicol
Ind Health 1998;14:25-39.

56. Moccia RD, Fox GA, Britton A. A quantitative assessment of thyroid histopathology of herring gulls from the Great Lakes and a hypothesis on the causal role of environmental contaminants. J Wildl Dis 1986;22:60-70.

57. Rice DC. Behavioral impairment produced by low-level postnatal PCB exposure in monkeys. Environ Res 1999;80(2 pt 2):S113-21.

58. Koopman-Esseboom C, Morse DC, Weisglas-Kuperus N, Lutkeschipholt IJ,
Van der Paauw CG, Tuinstra LG, et al. Effects of dioxins and polychlorinated
biphenyls on thyroid hormone status of pregnant women and their infants. Pediatr
Res 1994;36:468-73.

59. Osius N, Karmaus W, Kruse H, Witten J. Exposure to polychlorinated
biphenyls and levels of thyroid hormones in children. Environ Health Perspect

60. Tilson HA, Kodavanti PR. Neurochemical effects of polychlorinated biphenyls:
an overview and identification of research needs. Neurotoxicology 1997;18:727-43.

61. Jacobson JL, Jacobson SW. Effects of in utero exposure to PCBs and related
contaminants on cognitive functioning in young children. J Pediatr 1990;

62. Lonky E, Reihman J, Darvill T, Mather J, Daly H. Neonatal behavioral assessment scale performance in humans influenced by maternal consumption of environmentally contaminated Lake Ontario fish. J Great Lakes Res 1996;22:198-212.

63. Muckle G, Dewailly E, Ayotte P. Prenatal exposure of Canadian children to
polychlorinated biphenyls and mercury. Can J Public Health 1998;89(Suppl

64. Lauder JM. Neurotransmitters as morphogens. Prog Brain Res 1988;73:365-87.

65. Ahlbom J, Fredriksson A, Eriksson. Exposure to an organophosphate (DFP)
during a defined period in neonatal life induces permanent changes in brain
muscarinic receptors and behavior in adult mice. Brain Res 1995;677:13-9.

66. Lauder JM, Schambra UB. Morphogenic roles of acetylcholine. Environ Health
Perspect 1999;107(Suppl 1):65-9.

67. Bigbee JW, Sharma KV, Gupta JJ, Dupree JL. Morphogenic role for acetylcholinesterase in axonal outgrowth during neural development. Environ Health Perspect 1999;107(Suppl 1):81-7.

68. Rice DC. Issues in developmental neurotoxicology: interpretation and implications of the data. Can J Public Health 1998;89(Suppl 1):S31-6,S34-40.

69. Hill RH Jr, Head SL, Baker S, Gregg M, Shealy DB, Bailey SL, et al. Pesticide
residues in urine of adults living in the United States: reference range concentrations. Environ Res 1995;71:99-108.

70. Archibeque-Engle SL, Tessari JD, Winn DT, Keefe TJ, Nett TM, Zheng T.
Comparison of organochlorine pesticide and polychlorinated biphenyl residues in
human breast adipose tissue and serum. J Toxicol Environ Health 1997;52:285-93.

71. Reiter LW, DeRosa C, Kavlock RJ, Lucier G, Mac MJ, Melillo J, et al. The US
Federal Framework for Research on Endocrine Disruptors and an analysis of
research programs supported during fiscal year 1996. Environ Health Perspect

72. International Joint Commission. Open letter to Great Lakes leaders and the
Great Lakes community. In: Tenth biennial report on Great Lakes water quality.
Washington/Ottawa: The Commission; 2000. p. v. Available:
/comm/10br/en (accessed 2000 Oct 27).

73. Division of Laboratory Sciences. Biomonitoring program. Atlanta: National
Centre for Environmental Health, US Centers for Disease Control and Prevention.
Available: (accessed 2000 Oct 27).

74. Horton R. The new public health of risk and radical engagement. Lancet 1998;352:251-2.